NEWS | EMA New Fee Regulation effective January 2025

The European Medicines Agency (EMA) charges fees for the services it provides. As of 1 January 2025, EMA's fees are governed by Regulation (EU) 2024/568. This is known as the 'New fee regulation'. Current rules apply still apply until 31 December 2024.

The European Medicines Agency (EMA) charges fees for the services it provides. As of 1 January 2025, EMA's fees are governed by Regulation (EU) 2024/568. This is known as the 'New fee regulation'. Current rules apply still apply until 31 December 2024.
December 17, 2024

Starting January 1, 2025, Regulation (EU) 2024/568 on EMA fees will take effect. Key updates include:

  • Update of fee structures, calculated per procedure and based on actual costs incurred across Member States and EMA
  • Pre-payment required for parallel distribution, certificates of medicinal products, and scientific advice.
  • Introduction of administrative charges for withdrawal and for changes to the intended submission date
  • Removal of certain fees (e.g., for Type I variations and renewals).
  • Introduction of new fees (e.g., for PreSubmission, Referrals and re-examination of MA applications / opinions)

 

For details, visit: EMA NEW FEE REGULATION 

For further questions, contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENTS | Asphalion present at Key events this year

At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices. 

EVENT | DIA Europe

DIA Europe 2026 will take place in Rotterdam from 24–26 March 2026. As Europe’s largest neutral conference in the life sciences sector, it will gather 1,500 professionals from over 50 countries for three days of exchange and collaboration. The programme features 10 dynamic tracks covering key areas such as Clinical Trials Innovation, AI & Real-World Evidence, Innovative Therapies, Medical Devices, and Pharmacovigilance, alongside 80+ sessions and contributions from 300+ experts, regulatory authorities, HTA bodies, payers, and patient organizations—offering a key platform to drive innovation and informed decision-making in healthcare.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting